SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

228.61

+1.33%↑

Search

Merck KGaA

Suletud

SektorTervishoid

114.45 -1.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

113.25

Max

117

Põhinäitajad

By Trading Economics

Sissetulek

-142M

667M

Müük

152M

5.4B

P/E

Sektori keskmine

26.27

56.602

Aktsiakasum

2.2

Dividenditootlus

1.34

Kasumimarginaal

12.311

EBITDA

85M

1.6B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+42.4% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.34%

2.45%

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

33B

98B

Eelmine avamishind

115.66

Eelmine sulgemishind

114.45

Uudiste sentiment

By Acuity

30%

70%

80 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Merck KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. mai 2025, 08:36 UTC

Tulu
Suurimad hinnamuutused turgudel

Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks

15. mai 2025, 05:25 UTC

Tulu

Merck KGaA Cuts Outlook Amid Macroeconomic Challenges

28. apr 2025, 11:25 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck to Buy SpringWorks for $3.9 Billion -- Update

28. apr 2025, 06:41 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal

15. mai 2025, 08:21 UTC

Peamised uudised
Tulu
Suurimad hinnamuutused turgudel

Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks

15. mai 2025, 06:53 UTC

Market Talk
Tulu

Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q EBITDA EUR1.48B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA Now Sees 2025 EBITDA Before One-Time Items Between EUR5.8B and EUR6.4B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA Had Seen 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

15. mai 2025, 05:00 UTC

Tulu

Analysts Saw Merck KGaA 1Q Adj EPS at EUR2.17

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA Cuts 2025 View

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q After-Tax Profit EUR738M

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q Adj EPS EUR2.12

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q Sales EUR5.28B

15. mai 2025, 05:00 UTC

Tulu

Analysts Saw Merck KGaA 1Q Ebitda Before One-Time Items EUR1.51B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q EBIT EUR1.01B

15. mai 2025, 05:00 UTC

Tulu

Merck KGaA 1Q Ebitda Before One-Time Items EUR1.535B

15. mai 2025, 05:00 UTC

Tulu

Analysts Saw Merck KGaA 1Q Net Sales at EUR5.28B

28. apr 2025, 15:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk

28. apr 2025, 09:20 UTC

Kuumad aktsiad

Stocks to Watch Monday: DoorDash, Merck, Spirit AeroSystems, Airbus -- WSJ

28. apr 2025, 08:36 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Germany's Merck's Deal to Acquire SpringWorks Makes Strategic Sense, but Price in Focus -- Market Talk

28. apr 2025, 06:06 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck: Acquisition Will Strengthen Merck Healthcare Presence in U.S.

28. apr 2025, 06:05 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck: Planned Acquisition Will Immediately Add Revenue, Accelerate Growth

28. apr 2025, 06:05 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck: Deal Is for Purchase Price of $47 a Share in Cash

28. apr 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

Germany's Merck to Buy SpringWorks for About $3.9B

28. apr 2025, 06:02 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Germany's Merck to Buy SpringWorks Therapeutics

24. apr 2025, 22:51 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

Võrdlus sarnastega

Hinnamuutus

Merck KGaA Prognoos

Hinnasiht

By TipRanks

42.4% tõus

12 kuu keskmine prognoos

Keskmine 164.33 EUR  42.4%

Kõrge 190 EUR

Madal 107 EUR

Põhineb 10 Wall Streeti analüütiku instrumendi Merck KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

8

Osta

1

Hoia

1

Müü

Tehniline skoor

By Trading Central

121.15 / 123.55Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

80 / 382 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Merck KGaA

There is no Profile data available for MRK.BE.